Corticosteroids, antivirals, interferons, and monoclonal antibodies directed against immune system proteins, such as interleukin-6 (IL-6), or against certain SARS-CoV-2-specific targets were investigated in order to tackle either the viral replication cycle or the inflammation related to infection [4,5,6]. The gene discussed is IL6; the disease is infection.